Atlas Trials

A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

Clinical trial NCT00401570 · COMPLETED

Trial details

NCT number
NCT00401570
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2005-03-01
Primary completion
2008-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.